These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4953227)

  • 1. [Assay of the virulence of anti-anthrax vaccine in mice. Experimental results and practical application].
    Ribot JJ; Gilbert J
    Rev Elev Med Vet Pays Trop; 1965; 18(1):9-17. PubMed ID: 4953227
    [No Abstract]   [Full Text] [Related]  

  • 2. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
    Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The behaviour of virulent Bacillus anthracis strain AO843 in rabbits.
    Fasanella A; Scasciamacchia S; Garofolo G
    Vet Microbiol; 2009 Jan; 133(1-2):208-9. PubMed ID: 18650035
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vaccination strategies for anthrax prevention].
    Beyer W
    Berl Munch Tierarztl Wochenschr; 2004; 117(11-12):508-24. PubMed ID: 15584433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus anthracis, a story of nature subverted by man.
    Baillie LW
    Lett Appl Microbiol; 2005; 41(3):227-9. PubMed ID: 16108911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terrorism symposium update and conclusion.
    Bronze MS; Huycke MM; Greenfield RA
    J Okla State Med Assoc; 2003 Dec; 96(12):575-8. PubMed ID: 14965028
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of anthrax DNA vaccines.
    Ferrari ME; Hermanson G; Rolland A
    Curr Opin Mol Ther; 2004 Oct; 6(5):506-12. PubMed ID: 15537052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-toxigenic derivatives of the Ames strain of Bacillus anthracis are fully virulent for mice: role of plasmid pX02 and chromosome in strain-dependent virulence.
    Welkos SL; Vietri NJ; Gibbs PH
    Microb Pathog; 1993 May; 14(5):381-8. PubMed ID: 8366815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infections by Bacillus anthracis].
    Biederbick W; Fock R; Güttler K; Veit C
    Dtsch Med Wochenschr; 2002 Apr; 127(15):809-14. PubMed ID: 11951140
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current status of anthrax or black fever].
    Chantal J
    Med Trop (Mars); 1997; 57(3 Suppl):52-60. PubMed ID: 9513179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a subunit vaccine against Bacillus anthracis.
    Chichester JA; Musiychuk K; de la Rosa P; Horsey A; Stevenson N; Ugulava N; Rabindran S; Palmer GA; Mett V; Yusibov V
    Vaccine; 2007 Apr; 25(16):3111-4. PubMed ID: 17280756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthrax capsule vaccine protects against experimental infection.
    Chabot DJ; Scorpio A; Tobery SA; Little SF; Norris SL; Friedlander AM
    Vaccine; 2004 Nov; 23(1):43-7. PubMed ID: 15519706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress on the vaccine for anthrax].
    Zhan DW; Wang P; Wang LC; Zhang ZS
    Wei Sheng Wu Xue Bao; 2005 Feb; 45(1):149-52. PubMed ID: 15847185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for improved anthrax vaccines.
    Brey RN
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1266-92. PubMed ID: 15935874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use.
    Fasanella A; Tonello F; Garofolo G; Muraro L; Carattoli A; Adone R; Montecucco C
    Vaccine; 2008 Oct; 26(45):5684-8. PubMed ID: 18775462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relationship between inoculum dose of anthrax spores and survival time of mice.
    Seto K; Takizawa T
    Natl Inst Anim Health Q (Tokyo); 1969; 9(3):129-35. PubMed ID: 4983668
    [No Abstract]   [Full Text] [Related]  

  • 17. A review of anthrax in the workplace.
    Mayhan SC
    J Ark Med Soc; 2003 Feb; 99(8):264-7. PubMed ID: 12638469
    [No Abstract]   [Full Text] [Related]  

  • 18. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
    Gupta M; Alam S; Bhatnagar R
    Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthrax: virulence and vaccines.
    Farrar WE
    Ann Intern Med; 1994 Sep; 121(5):379-80. PubMed ID: 8042830
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
    Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.